Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVF
4376
INVO Fertility Inc
IVF
$1.89M
| $25K | ﹤0.01% |
24
+1
| +4% | +$1.14K |
|
4377
CaliberCos
CWD
$4.6M
| $24.9K | ﹤0.01% |
+1,993
| New | +$26.2K |
|
|
SSY
4378
DELISTED
SunLink Health Systems
SSY
| $23.8K | ﹤0.01% |
29,737
+5,096
| +21% | +$4.13K |
|
|
AUMN
4379
DELISTED
Golden Minerals Company
AUMN
| $23.1K | ﹤0.01% |
85,738
-1,104
| -1% | -$387 |
|
|
MYSE
4380
Myseum.AI Inc
MYSE
$13.1M
| $23.1K | ﹤0.01% |
17,752
-1,610
| -8% | -$2.18K |
|
|
CLLS
4381
Cellectis
CLLS
$285M
| $23.1K | ﹤0.01% |
10,776
| – | – |
|
4382
Biofrontera
BFRI
$16.3M
| $22.8K | ﹤0.01% |
17,102
-440
| -3% | -$504 |
|
|
ADAG
4383
Adagene
ADAG
$272M
| $22.7K | ﹤0.01% |
10,309
| – | – |
|
4384
AGM Group Holdings
AGMH
$2.48M
| $22.2K | ﹤0.01% |
258
| – | – |
|
|
ACHL
4385
DELISTED
Achilles Therapeutics
ACHL
| $22K | ﹤0.01% |
21,590
| – | – |
|
|
YHC
4386
LQR House Inc
YHC
$2.33M
| $21.7K | ﹤0.01% |
+11
| New | +$26.8K |
|
4387
Beneficient
BENF
$43.5M
| $21.6K | ﹤0.01% |
2,194
+873
| +66% | +$17.2K |
|
4388
Hitek Global
HKIT
$27.3M
| $21.6K | ﹤0.01% |
4
| – | – |
|
4389
Taoping
TAOP
$6.96M
| $21.5K | ﹤0.01% |
1,010
-5
| -0.5% | -$90 |
|
4390
Eterna Therapeutics
ERNA
$4.91M
| $21.5K | ﹤0.01% |
54
-9
| -14% | -$5.76K |
|
|
BLRX
4391
BioLineRX
BLRX
$11.8M
| $21.4K | ﹤0.01% |
1,000
| – | – |
|
|
DADA
4392
DELISTED
Dada Nexus
DADA
| $20.9K | ﹤0.01% |
10,974
-59,209
| -84% | -$77.5K |
|
4393
MicroCloud Hologram
HOLO
$36.9M
| $20.3K | ﹤0.01% |
+70
| New | +$24.6K |
|
|
SELX
4394
DELISTED
Semilux International
SELX
| $19.9K | ﹤0.01% |
16,572
| – | – |
|
4395
Artelo Biosciences
ARTL
$2.51M
| $19.8K | ﹤0.01% |
964
-136
| -12% | -$3.11K |
|
4396
T Stamp
IDAI
$18.1M
| $19.5K | ﹤0.01% |
5,894
+2,238
| +61% | +$12.1K |
|
|
VRPX
4397
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
| $19.4K | ﹤0.01% |
+1,119
| New | +$27.8K |
|
|
SNT
4398
Senstar Technologies
SNT
$43.2M
| $19.3K | ﹤0.01% |
12,188
| – | – |
|
4399
Freightos
CRGO
$65.6M
| $19.1K | ﹤0.01% |
13,290
| – | – |
|
|
ICCT
4400
DELISTED
iCoreConnect
ICCT
| $18.9K | ﹤0.01% |
2,706
-308
| -10% | -$3.68K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.